Co-Diagnostics, Inc. (CODX) News

Co-Diagnostics, Inc. (CODX): $1.11

0.02 (-1.77%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Filter CODX News Items

CODX News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

CODX News Highlights

  • For CODX, its 30 day story count is now at 2.
  • Over the past 28 days, the trend for CODX's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about CODX are DX, CM and APP.

Latest CODX News From Around the Web

Below are the latest news stories about CO-DIAGNOSTICS INC that investors may wish to consider to help them evaluate CODX as an investment opportunity.

Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that it has submitted its Co-Dx™ PCR COVID-19 test with Co-Dx PCR Pro™ instrument for review by the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA). The submission includes the PCR Pro instrument, COVID-19 detection test, and mobile app, all designed for use in point-of-

Yahoo | December 27, 2023

Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that Co-Diagnostics will be presenting at the Piper Sandler 35th Annual Healthcare Conference in New York City, New York on November 30, 2023.

Yahoo | November 29, 2023

Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2023 Earnings Call Transcript

Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2023 Earnings Call Transcript November 9, 2023 Co-Diagnostics, Inc. beats earnings expectations. Reported EPS is $-0.2, expectations were $-0.29. Operator: Hello. Welcome to the Co-Diagnostics Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note today’s event is being recorded. I would now like […]

Yahoo | November 10, 2023

Q3 2023 Co-Diagnostics Inc Earnings Call

Q3 2023 Co-Diagnostics Inc Earnings Call

Yahoo | November 10, 2023

Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended September 30, 2023.

Yahoo | November 9, 2023

Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development

Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced a grant awarded by the Bill & Melinda Gates Foundation to support the tuberculosis (TB) test in development, designed to be run on the upcoming Co-Dx™ PCR platform*. The amount awarded is $8.976 million.

Yahoo | November 2, 2023

Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today the list of events it has chosen to exhibit at or attend during November, 2023, which strategically align with its mission of increasing accessibility of affordable gold-standard PCR diagnostics around the world.

Yahoo | October 31, 2023

Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and Webcast

Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2023 results on Thursday, November 9, 2023, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts and institutional investors. Management on the call will include Dwight Egan, Chief Executive

Yahoo | October 26, 2023

Co-Diagnostics, Inc. to Host Booth at CASMET Symposium October 23-25

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting a booth this week at the Caribbean Association of Medical Technologies (CASMET) Scientific Symposium and BGM, held in Barbados October 22-26, 2023.

Yahoo | October 23, 2023

Co-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in Johannesburg, South Africa

Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today that the Company will be hosting a booth this week at Africa Health/Medlab Africa in Johannesburg, South Africa on October 17-19, 2023.

Yahoo | October 16, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!